Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
3 results loaded, newest first. End of these results.
Clinical-stage biopharmaceutical company Sionna Therapeutics Inc. (NASDAQ: SION ) announced topline clinical trial results from two nucleotide binding domain 1 (NBD1) stabilizer candidate programs targeting cystic fibrosis (CF). The findings indicated that its PreciSION CF Phase 2a trial assessing SION-719 missed its k
Thermo Fisher Scientific Inc. (NYSE: TMO ) on Thursday reported second-quarter adjusted earnings of $6.03 per share, beating the street view of $5.71. The life science giant’s quarterly sales of $11.994 billion increased 10% year-over-year, beating the analyst consensus estimate of $11.701 billion. Organic revenue grow
Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT ) is collaborating with Thermo Fisher Scientific Inc. (NYSE: TMO ) to support the Phase 3 development and potential commercialization of ARCT-032, the company’s investigational messenger RNA therapy for cystic fibrosis. Read Also: Thermo Fisher Flags 'Modest Inflation'